About Hospital Universitario de Bellvitge
El Hospital Universitario de Bellvitge, y antes denominado Hospital Príncipes de España, Ciudad Sanitaria de Bellvitge y Ciudad Sanitaria y Universitaria de Bellvitge, es un hospital de titularidad ...
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Hospital Universitario de Bellvitge
During the past decade, Hospital Universitario de Bellvitge conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 15 clinical trials were completed, i.e. on
average, 30.6% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 11 clinical trials were completed. i.e. 40.7%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital Universitario de Bellvitge" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "Fundacion SEIMC-GESIDA" with 4 trials
sponsored, "Genentech, Inc." with 4 trials sponsored, "Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa" with 4 trials sponsored and "Hospital Universitari de Bellvitge"
with 4 trials sponsored. Other sponsors include 42 different institutions and
companies that sponsored additional 43 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario de Bellvitge"
#1 collaborator was "Hospital Universitari de Bellvitge" with 3 trials as a collaborator, "Boston Scientific Corporation" with 2 trials as a collaborator, "Carlos III Health Institute" with 2 trials as a collaborator, "European Commission" with 2 trials as a collaborator and "Gilead Sciences" with 2 trials as a collaborator. Other collaborators include 61 different institutions and companies that were
collaborators in the rest 71 trials.
Clinical Trials Conditions at Hospital Universitario de Bellvitge
According to Clinical.Site data, the most researched conditions in "Hospital Universitario de Bellvitge" are
"COVID-19 Pneumonia" (3 trials), "Crohn Disease" (3 trials), "Idiopathic Pulmonary Fibrosis" (3 trials), "Cardiovascular Diseases" (2 trials) and "Community-acquired Pneumonia" (2 trials). Many other conditions were trialed in "Hospital Universitario de Bellvitge" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Universitario de Bellvitge
Most popular intervention types in "Hospital Universitario de Bellvitge" are "Drug" (44 trials), "Device" (13 trials), "Procedure" (11 trials), "Other" (5 trials) and "Biological" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (15 trials), "Faricimab" (5 trials), "Sham Procedure" (5 trials), "Aflibercept" (3 trials) and "Azacitidine" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Universitario de Bellvitge
The vast majority of trials in "Hospital Universitario de Bellvitge" are
73 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Hospital Universitario de Bellvitge
Currently, there are NaN active trials in "Hospital Universitario de Bellvitge".
undefined are not yet recruiting,
15 are recruiting,
8 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 41 completed trials in Hospital Universitario de Bellvitge,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Universitario de Bellvitge, 6 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 19 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 11 trials, and there were
also 12 trials that are defined as “Not Applicable".